CMH :: Clinical and Molecular Hepatology

Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study

Vito Fiore, Andrea De Vito, Elena Rastrelli, Valentina Manca, Giuseppe De Matteis, Roberto Ranieri, Emanuele Pontali, Nicholas Geremia, Sandro Panese, Giulio Starnini, Giordano Madeddu, Sergio Babudieri

Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice

Nadia Marascio, Salvatore Rotundo, Angela Quirino, Giovanni Matera, Maria Carla Liberto, Chiara Costa, Alessandro Russo, Enrico Maria Trecarichi, Carlo Torti

World Journal of Gastroenterology.2022; 28(12): 1226. CrossRef

HCV inhibits M2a, M2b and M2c macrophage polarization via HCV core protein engagement with Toll‑like receptor 2

Shixing Zhao, Meng Si, Xianpei Deng, Dengqin Wang, Lingbin Kong, Qianqian Zhang

Experimental and Therapeutic Medicine.2022;[Epub] CrossRef

Circulating Genotypes of Hepatitis C Virus in Italian Patients before and after the Application of Wider Access Criteria to HCV Treatment

Daniela Zago, Irene Pozzetto, Monia Pacenti, Giuseppina Brancaccio, Silvia Ragolia, Monica Basso, Saverio Giuseppe Parisi

The Open Microbiology Journal.2022;[Epub] CrossRef

The Role of the Microbiota Gut–Liver Axis during HCV Chronic Infection: A Schematic Overview

Nadia Marascio, Carmen De Caro, Angela Quirino, Maria Mazzitelli, Emilio Russo, Carlo Torti, Giovanni Matera

Journal of Clinical Medicine.2022; 11(19): 5936. CrossRef

Epidemiology and Genotype Distribution of Hepatitis C Virus in Russia

Nikolay Pimenov, Dmitry Kostyushev, Svetlana Komarova, Anastasia Fomicheva, Alexander Urtikov, Olga Belaia, Karina Umbetova, Olga Darvina, Natalia Tsapkova, Vladimir Chulanov

Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection

Journal of Clinical Medicine.2021; 10(2): 221. CrossRef

Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level

Carlo Torti, Vincenzo Scaglione, Bruno Mario Cesana, Chiara Costa, Nadia Marascio, Elisabetta Schiaroli, Chiara Busti, Sabrina Bastianelli, Maria Mazzitelli, Enrico Maria Trecarichi, Daniela Francisci

Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report

Fabián Aldunate, Natalia Echeverría, Daniela Chiodi, Pablo López, Adriana Sánchez-Cicerón, Martín Soñora, Juan Cristina, Gonzalo Moratorio, Nelia Hernández, Pilar Moreno

Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy

Nadia Marascio, Angela Costantino, Stefania Taffon, Alessandra Lo Presti, Michele Equestre, Roberto Bruni, Giulio Pisani, Giorgio Settimo Barreca, Angela Quirino, Enrico Maria Trecarichi, Chiara Costa, Maria Mazzitelli, Francesca Serapide, Giovanni Matera

Journal of Clinical Medicine.2021; 10(8): 1655. CrossRef

Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals

International Journal of Molecular Sciences.2020; 21(7): 2583. CrossRef

HCV Antibody Prevalence and Genotype Evolution in a Teaching Hospital, Calabria Region, Southern Italy Over A Decade (2008-2018)

Nadia Marascio, Maria Mazzitelli, Giuseppe G.M. Scarlata, Aida Giancotti, Giorgio S. Barreca, Angelo G. Lamberti, Francesca Divenuto, Chiara Costa, Enrico M. Trecarichi, Giovanni Matera, Maria C. Liberto, Carlo Torti

The Open Microbiology Journal.2020; 14(1): 84. CrossRef

microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and De Novo Lipogenesis

Eun Byul Lee, Pil Soo Sung, Jung-Hee Kim, Dong Jun Park, Wonhee Hur, Seung Kew Yoon

Dissimilar Conservation Pattern in Hepatitis C Virus Mutant Spectra, Consensus Sequences, and Data Banks

Carlos García-Crespo, María Eugenia Soria, Isabel Gallego, Ana Isabel de Ávila, Brenda Martínez-González, Lucía Vázquez-Sirvent, Jordi Gómez, Carlos Briones, Josep Gregori, Josep Quer, Celia Perales, Esteban Domingo

Journal of Clinical Medicine.2020; 9(11): 3450. CrossRef

Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals

Hye Won Lee, Dai Hoon Han, Hye Jung Shin, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim

The remaining challenges of HCV treatment in the direct‐acting antivirals era

Journal of Gastroenterology and Hepatology.2019; 34(11): 1891. CrossRef